CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Fraxel Laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02988622
NCT02988622N/ACompleted
CompareCT.gov

1550-nm Non Ablative Laser (Fraxel) Versus Ablative 10,600-nm Carbon Dioxide (CO2) Fractional Laser in the Treatment of Surgical and Traumatic Scars: A Comparison Study on Efficacy, Treatment Regimen, and Cost.

Marta Hemmingson-Van Beek·interventional·Posted Dec 9, 2016·Updated Oct 18, 2018

In Brief

A clinical study evaluating Fraxel Laser and CO2 Laser for Scar. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the 1550-nm non-ablative Fraxel laser (referred to as Fraxel Laser in this application) to the ablative 10,600-nm carbon dioxide fractional laser (referred to as CO2 Laser in this application) to determine if one is superior to the other in improving the appearance of scars over a series of three treatments. In addition, the investigators hope to identify a more cost-effective method to improve the appearance of scars caused by surgery or trauma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScar
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 9, 2016
Enrollment StartJan 1, 2016
Primary CompletionJan 15, 2018
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.6 years ago

Interventions

Fraxel Laserdevice

One half of the scar is treated with Fraxel Laser

CO2 Laserdevice

One half of the scar is treated with CO2 Laser.